These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 34566723)

  • 1. Psychedelics and Neuroplasticity: A Systematic Review Unraveling the Biological Underpinnings of Psychedelics.
    de Vos CMH; Mason NL; Kuypers KPC
    Front Psychiatry; 2021; 12():724606. PubMed ID: 34566723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Towards an understanding of psychedelic-induced neuroplasticity.
    Calder AE; Hasler G
    Neuropsychopharmacology; 2023 Jan; 48(1):104-112. PubMed ID: 36123427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroplasticity as a convergent mechanism of ketamine and classical psychedelics.
    Aleksandrova LR; Phillips AG
    Trends Pharmacol Sci; 2021 Nov; 42(11):929-942. PubMed ID: 34565579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemical Mechanisms Underlying Psychedelic-Induced Neuroplasticity.
    Olson DE
    Biochemistry; 2022 Feb; 61(3):127-136. PubMed ID: 35060714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. From psychiatry to neurology: Psychedelics as prospective therapeutics for neurodegenerative disorders.
    Kozlowska U; Nichols C; Wiatr K; Figiel M
    J Neurochem; 2022 Jul; 162(1):89-108. PubMed ID: 34519052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychedelics in Psychiatry: Neuroplastic, Immunomodulatory, and Neurotransmitter Mechanisms.
    Inserra A; De Gregorio D; Gobbi G
    Pharmacol Rev; 2021 Jan; 73(1):202-277. PubMed ID: 33328244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beating pain with psychedelics: Matter over mind?
    Elman I; Pustilnik A; Borsook D
    Neurosci Biobehav Rev; 2022 Mar; 134():104482. PubMed ID: 34922987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychedelic-inspired approaches for treating neurodegenerative disorders.
    Saeger HN; Olson DE
    J Neurochem; 2022 Jul; 162(1):109-127. PubMed ID: 34816433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How do serotonergic psychedelics treat depression: The potential role of neuroplasticity.
    Artin H; Zisook S; Ramanathan D
    World J Psychiatry; 2021 Jun; 11(6):201-214. PubMed ID: 34168967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5-HT2ARs Mediate Therapeutic Behavioral Effects of Psychedelic Tryptamines.
    Cameron LP; Patel SD; Vargas MV; Barragan EV; Saeger HN; Warren HT; Chow WL; Gray JA; Olson DE
    ACS Chem Neurosci; 2023 Feb; 14(3):351-358. PubMed ID: 36630260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dreams and Psychedelics: Neurophenomenological Comparison and Therapeutic Implications.
    Kraehenmann R
    Curr Neuropharmacol; 2017; 15(7):1032-1042. PubMed ID: 28625125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bibliometric Analysis of Academic Journal Articles Reporting Results of Psychedelic Clinical Studies.
    Weleff J; Akiki TJ; Barnett BS
    J Psychoactive Drugs; 2023; 55(4):434-444. PubMed ID: 36218281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An Assessment of Psychedelic Knowledge Among People Using Psychedelics Naturalistically.
    Kruger DJ; Glynos NG; Fields CW; Herberholz M; Boehnke KF
    J Psychoactive Drugs; 2023; 55(4):420-424. PubMed ID: 36328419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The therapeutic potential of microdosing psychedelics in depression.
    Kuypers KPC
    Ther Adv Psychopharmacol; 2020; 10():2045125320950567. PubMed ID: 32922736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular targets of psychedelic-induced plasticity.
    Jaster AM; de la Fuente Revenga M; González-Maeso J
    J Neurochem; 2022 Jul; 162(1):80-88. PubMed ID: 34741320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroplasticity-related mechanisms underlying the antidepressant-like effects of traditional herbal medicines.
    Hirshler Y; Doron R
    Eur Neuropsychopharmacol; 2017 Oct; 27(10):945-958. PubMed ID: 28807619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term use of psychedelic drugs is associated with differences in brain structure and personality in humans.
    Bouso JC; Palhano-Fontes F; Rodríguez-Fornells A; Ribeiro S; Sanches R; Crippa JA; Hallak JE; de Araujo DB; Riba J
    Eur Neuropsychopharmacol; 2015 Apr; 25(4):483-92. PubMed ID: 25637267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Evolved Psychology of Psychedelic Set and Setting: Inferences Regarding the Roles of Shamanism and Entheogenic Ecopsychology.
    Winkelman MJ
    Front Pharmacol; 2021; 12():619890. PubMed ID: 33732156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Registered clinical studies investigating psychedelic drugs for psychiatric disorders.
    Siegel AN; Meshkat S; Benitah K; Lipsitz O; Gill H; Lui LMW; Teopiz KM; McIntyre RS; Rosenblat JD
    J Psychiatr Res; 2021 Jul; 139():71-81. PubMed ID: 34048997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The neurobiology of psychedelic drugs: implications for the treatment of mood disorders.
    Vollenweider FX; Kometer M
    Nat Rev Neurosci; 2010 Sep; 11(9):642-51. PubMed ID: 20717121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.